Prestigious Prize Presented to Distinguish Leading-Edge Researchers in Europe Dr. Schumacher Recognized for the Development of Technologies to Study the Role of the Immune System in Cancer Progression and for the Improvement of Cancer Diagnosis and Treatment SOUTH SAN FRANCISCO, Calif. , Jan.
SOUTH SAN FRANCISCO, Calif. , Jan. 05, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that David Chang , M.D., Ph.D., President, Chief
